Eli Lilly (LLY) is partnering with Amazon’s (AMZN) pharmacy unit to deliver drug prescriptions sent to LillyDirect, its direct-to-consumer service, Reuters’ Patrick Wingrove reports. Lilly’s platform was launched in January, enabling patients to obtain their migraine, diabetes and obesity drugs, Zepbound, directly from the company via delivery from online pharmacy Truepill. Prescriptions sent to LillyDirect Pharmacy Solutions will now be delivered by either Amazon Pharmacy or Truepill, depending on the patient’s insurance coverage and other factors, according to the report.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on LLY:
- Eli Lilly CAO Zakrowski sells 750 common shares
- Eli Lilly announces results from ‘first-of-its-kind study’ of lebrikizumab
- Eli Lilly (NYSE:LLY) Slips after Surprise FDA Snub
- Eli Lilly falls $3.16 to $777 after FDA delays decision on Alzheimer’s drug
- Eli Lilly reports FDA to convene PCNS meeting to discuss TRAILBLAZER-ALZ 2 trial
